CareDx (CDNA) Misses Q4 EPS by 6c

CareDx (NASDAQ: CDNA) reported Q4 EPS of ($0.03), $0.06 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $79.2 million versus the consensus estimate of $78.09 million.

GUIDANCE:

CareDx sees FY2022 revenue of $330-350 million, versus the consensus of $343 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
• Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance